New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export MS’s income statement to Excel — free account
Morgan Stanley
MSMorgan Stanley’s revenue for fiscal 2025 (year ended December 2025) was $119.7 billion, up 11.5% from fiscal 2024.
- Revenue
- +6.69%
- EPS
- +8.21%
- Free cash flow
- n/m
- Total debt
- +17.2%
Quarter to September 2026, against a year earlier
165.69
9.29
−5.31%
After hours trading: 166.80, up 0.67%, last trade 4:45pm Eastern.
Follow MS
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 157.7% in Q3 FY26, the highest of these four quarters.
ROEROIC
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 16.4% | 17.2% | 18.9% | 18.9% |
| ROIC | 57.1% | 65.8% | 123.3% | 157.7% |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has grown 11.2%; book value has grown 6.80%.
RevenueBook value
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 1.0× | 1.1× | 1.1× |
| Book value | 1.0× | 1.0× | 1.1× | 1.1× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 5 | 4 |
| 16.37% | 17.18% | 18.87% | 18.91% | ||
| 1.23% | 1.21% | 1.29% | 1.30% | ||
ROIC |
57.06% | 65.75% | 123.28% | 157.69% | |
Return on Tangible Assets |
(8.93%) | (6.97%) | (8.12%) | (7.97%) | |
Average Days of Receivables |
1,198.18 | 1,258.73 | 1,284.85 | 1,281.94 | |
Free Cash Flow per Share |
(13.21) | (2.53) | (11.96) | (39.73) | |
Free Cash Flow |
(20,787.00) | (3,950.00) | (18,582.00) | (61,506.00) | |
Capital Expenditures |
(2,898.00) | (2,939.00) | (2,995.00) | (3,227.00) | |
| Other line items | |||||
Cash ROIC |
(2.46%) | (0.44%) | (1.89%) | (6.26%) | |
Accounts Receivable Turnover |
0.33 | 0.32 | 0.32 | 0.31 | |
Accounts Payable Turnover |
0.02 | 0.02 | 0.02 | 0.02 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
17,670.32 | 20,080.73 | 20,417.03 | 18,520.44 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.22) | (0.22) | (0.22) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
33.02% | 32.88% | 32.51% | 32.64% | |
Share Based Compensation of Revenue |
1.61% | 1.58% | 1.59% | 1.64% | |
Interest Coverage |
1.45 | 1.47 | 1.52 | 1.52 | |
Operating CF/Net income |
(1.10) | (0.06) | (0.80) | (2.94) | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.62) | (0.65) | (0.68) | (0.77) | |
Revenue per Share |
76.02 | 79.23 | 82.88 | 84.55 | |
Operating CF per Share |
(11.37) | (0.65) | (10.03) | (37.65) | |
Capex per Share |
(1.84) | (1.88) | (1.93) | (2.08) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated Nov 18, 2026